These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 1531004)

  • 21. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Location, incidence, and malignant potential of duodenal gastrinomas.
    Thom AK; Norton JA; Axiotis CA; Jensen RT
    Surgery; 1991 Dec; 110(6):1086-91; discussion 1091-3. PubMed ID: 1745977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
    Jensen RT; Fraker DL
    JAMA; 1994 May; 271(18):1429-35. PubMed ID: 7513768
    [No Abstract]   [Full Text] [Related]  

  • 25. Gastrinoma: advances in localization and treatment.
    Norton JA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):845-61. PubMed ID: 9735137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
    MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
    Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
    Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
    Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resection of gastrinomas.
    Deveney CW; Deveney KE; Stark D; Moss A; Stein S; Way LW
    Ann Surg; 1983 Oct; 198(4):546-53. PubMed ID: 6138003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early surgical treatment of gastrinoma.
    Ellison EC; Carey LC; Sparks J; O'Dorisio TM; Mekhjian HS; Fromkes JJ; Caldwell JH; Thomas FB
    Am J Med; 1987 May; 82(5B):17-24. PubMed ID: 2884876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome.
    Ruszniewski P; Amouyal P; Amouyal G; Grangé JD; Mignon M; Bouché O; Bernades P
    Surgery; 1995 Jun; 117(6):629-35. PubMed ID: 7778027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent trend of diagnosis and treatment for Zollinger-Ellison syndrome].
    Imamura M; Komoto I; Doi R
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):147-51. PubMed ID: 15751623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study.
    Frucht H; Norton JA; London JF; Vinayek R; Doppman JL; Gardner JD; Jensen RT; Maton PN
    Gastroenterology; 1990 Dec; 99(6):1622-7. PubMed ID: 2227278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome.
    Thompson NW; Vinik AI; Eckhauser FE
    Ann Surg; 1989 Apr; 209(4):396-404. PubMed ID: 2930285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment and prognosis of gastrinoma.
    Norton JA
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):799-805. PubMed ID: 16253901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and outcome of patients with sporadic gastrinoma arising in the duodenum.
    Zogakis TG; Gibril F; Libutti SK; Norton JA; White DE; Jensen RT; Alexander HR
    Ann Surg; 2003 Jul; 238(1):42-8. PubMed ID: 12832964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patients with Zollinger-Ellison syndrome.
    Meko JB; Norton JA
    Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.
    Thom AK; Norton JA; Doppman JL; Miller DL; Chang R; Jensen RT
    Surgery; 1992 Dec; 112(6):1002-8; discussion 1008-9. PubMed ID: 1455303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.